معرفی
Rolf Henrik Berg is a Professor and Head of Innovation at the Department of Health Technology, Technical University of Denmark. As an organic synthetic chemist, he has made groundbreaking scientific contributions, including co-discovering artificial DNA analogues called PNA (Peptide Nucleic Acids) and photoanisotropic peptides. His work bridges academia and industry, evidenced by his role as co-inventor of over 40 US patents linked to FDA-cleared products and seven startup companies.
- Key Collaborations: Extensive projects with Technical University of Denmark and external institutions
- Leadership: Head of Innovation at DTU Health Tech, presenter at COMS2008 conference
Research Focus: Berg's work spans DNA analogues, nanomedicine, and biomaterials. His projects explore:
- Nanoparticle transport mechanisms for drug delivery
- Non-viral gene transfection systems
- Photoresponsive peptide materials
- High-tech entrepreneurship education
Scientific Impact: With 148+ publications and 14 major projects, his research drives innovation in biomedical engineering and nanotechnology. Current projects examine:
- Biomineralization and biomimetic materials
- Nanoparticle surface engineering
- HER2-targeted cancer therapies
- Blood-brain barrier drug delivery
Commercialization: As a prolific inventor, he has secured >40 patents that form the foundation for seven biotech startups. His educational initiatives focus on cultivating entrepreneurial mindsets in engineering students.
